Contact us to learn more about

our Premium Content: News alerts, weekly reports and conference planners

BIOMARKER:

NRAS mutation + BRAF mutation

Contact us to learn more about our Premium Content:

News alerts, weekly reports and conference planners

Entrez ID:

Related biomarkers:

‹

›

NRAS mutation + BRAF mutation	Colorectal Cancer	NRAS mutation + BRAF mutation	Colorectal Cancer	nivolumab Sensitive: C3 – Early Trials nivolumab Sensitive : C3	nivolumab Sensitive: C3 – Early Trials nivolumab Sensitive : C3
NRAS mutation + BRAF mutation	Ampulla of Vater Carcinoma	NRAS mutation + BRAF mutation	Ampulla of Vater Carcinoma	MEK inhibitor Sensitive: C4 – Case Studies MEK inhibitor Sensitive : C4	MEK inhibitor Sensitive: C4 – Case Studies MEK inhibitor Sensitive : C4
NRAS mutation + BRAF mutation	Non Small Cell Lung Cancer	NRAS mutation + BRAF mutation	Non Small Cell Lung Cancer	trametinib Resistant: D – Preclinical trametinib Resistant : D	trametinib Resistant: D – Preclinical trametinib Resistant : D
NRAS mutation + BRAF mutation	Melanoma	NRAS mutation + BRAF mutation	Melanoma	SCH772984 Sensitive: D – Preclinical SCH772984 Sensitive : D	SCH772984 Sensitive: D – Preclinical SCH772984 Sensitive : D